NASDAQ:SIEN Sientra (SIEN) Stock Price, News & Analysis → Like Tiny Crypto Retirement Funds (From Crypto 101 Media) (Ad) Free SIEN Stock Alerts $0.17 -0.04 (-18.69%) (As of 02/21/2024) Add Compare Share Share Today's Range$0.16▼$0.2050-Day Range$0.17▼$0.6852-Week Range$0.16▼$4.94Volume3.44 million shsAverage Volume4.15 million shsMarket Capitalization$2.08 millionP/E RatioN/ADividend YieldN/APrice Target$7.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Sientra alerts: Email Address Sientra MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside4,210.3% Upside$7.50 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment0.50Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($3.66) to ($2.05) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.92 out of 5 stars 3.3 Analyst's Opinion Consensus RatingSientra has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $7.50, Sientra has a forecasted upside of 4,210.3% from its current price of $0.17.Amount of Analyst CoverageSientra has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for SIEN. Previous Next 0.0 Dividend Strength Dividend YieldSientra does not currently pay a dividend.Dividend GrowthSientra does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SIEN. Previous Next 1.9 News and Social Media Coverage News SentimentSientra has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.64 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Sientra this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for SIEN on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat FollowsOnly 5 people have added Sientra to their MarketBeat watchlist in the last 30 days. This is a decrease of -17% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sientra insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.53% of the stock of Sientra is held by insiders.Percentage Held by InstitutionsOnly 15.38% of the stock of Sientra is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Sientra are expected to grow in the coming year, from ($3.66) to ($2.05) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Sientra is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sientra is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm Press8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)THIS cryptocurrency has gained 40% in 6 months. A crypto millionaire who has researched the space for a decade says it will go up 8,788% in 5 years. The name of this cryptocurrency is revealed right here: Click to get the name of the cryptocurrency About Sientra Stock (NASDAQ:SIEN)Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.Read More SIEN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SIEN Stock News HeadlinesMarch 18, 2024 | americanbankingnews.comSientra (NASDAQ:SIEN) Earns Hold Rating from Analysts at StockNews.comMarch 15, 2024 | finance.yahoo.comGlobal Gynecomastia Procedures Market Size To Exceed USD 1900 Million by 2033 | CAGR Of 8.05%March 19, 2024 | The Bull Report (Ad)The AI Bottleneck No One is Talking AboutRenewable energy is growing at an impressive speed - but not fast enough. This could be one of the greatest periods for the nuclear industry ever.March 10, 2024 | americanbankingnews.comStockNews.com Initiates Coverage on Sientra (NASDAQ:SIEN)March 7, 2024 | wsj.comFirm Retention Summary: SientraFebruary 17, 2024 | finance.yahoo.comSIEN Mar 2024 2.500 callFebruary 15, 2024 | finanznachrichten.deSientra, Inc.: Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 ProcessFebruary 15, 2024 | msn.comPlastic surgery company goes bust, files Chapter 11 bankruptcyMarch 19, 2024 | Colonial Metals (Ad)Central Bank Gold Heist In ProgressWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.February 15, 2024 | msn.comPlastic-surgery company goes bust, files Chapter 11 bankruptcyFebruary 14, 2024 | msn.comImplant Maker Sientra Cleared to Draw Deerfield Bankruptcy LoanFebruary 13, 2024 | marketwatch.comHealth Care Limits Losses Amid Defensive Bias -- Health Care RoundupFebruary 13, 2024 | wsj.comBreast-Implant Maker Sientra Files for BankruptcyFebruary 13, 2024 | benzinga.comNasdaq Down Over 2%; Marriott Earnings Top ViewsFebruary 13, 2024 | markets.businessinsider.comSientra Files For Bankruptcy; Stock Tanks 65%February 13, 2024 | msn.comBreast-Implant Maker Sientra Files Bankruptcy After Consumer PullbackFebruary 13, 2024 | benzinga.comDow Dips Over 300 Points; US Annual Inflation Slows to 3.1% In JanuaryFebruary 13, 2024 | msn.comSientra drops on filing of voluntary Chapter 11 BankruptcyFebruary 13, 2024 | wsj.comSurgical Aesthetics Company Sientra Files for BankruptcyFebruary 13, 2024 | finance.yahoo.comSientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 ProcessFebruary 1, 2024 | benzinga.comSientra Stock (NASDAQ:SIEN) Dividends: History, Yield and DatesJanuary 30, 2024 | businesswire.comGlobal Breast Implants Market Industry Trends and Global Forecasts 2023-2035 - Distribution by Gender, End User, Distribution Channel and Key Geographical Regions ...January 30, 2024 | msn.comSientra Secures Amendment for Financial FlexibilityJanuary 25, 2024 | uk.finance.yahoo.comGlobal Breast Implants Market Report 2023-2035: Global Breast Implants Industry Surges, Projected to Triple by 2035January 24, 2024 | uk.finance.yahoo.comNorth America Breast Reconstruction Market Forecasted to Reach USD 366.2 Million by 2030 Amid Surge in Breast Cancer CasesJanuary 3, 2024 | markets.businessinsider.comStrong Buy Rating for Elutia Amid Anticipated FDA Clearance and Robust Product GrowthDecember 21, 2023 | benzinga.comSientra Stock (NASDAQ:SIEN) Insider TradesSee More Headlines Receive SIEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sientra and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/10/2021Today3/18/2024Next Earnings (Estimated)4/04/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolNASDAQ:SIEN CUSIPN/A CIK1551693 Webwww.sientra.com Phone(805) 562-3500Fax805-562-8401Employees304Year FoundedN/APrice Target and Rating Average Stock Price Target$7.50 High Stock Price Target$10.00 Low Stock Price Target$5.00 Potential Upside/Downside+4,210.3%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($5.57) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-73,310,000.00 Net Margins-65.93% Pretax Margin-65.68% Return on EquityN/A Return on Assets-40.45% Debt Debt-to-Equity RatioN/A Current Ratio0.57 Quick Ratio0.31 Sales & Book Value Annual Sales$90.55 million Price / Sales0.02 Cash FlowN/A Price / Cash FlowN/A Book Value($0.04) per share Price / Book-4.35Miscellaneous Outstanding Shares11,960,000Free Float11,775,000Market Cap$2.08 million OptionableOptionable Beta2.04 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Ronald Menezes (Age 61)President, CEO & Director Comp: $501.18kMr. Andrew C. Schmidt (Age 63)Senior VP, Treasurer & CFO Comp: $365.4kMr. Oliver Christian Bennett (Age 47)Senior VP, Chief Legal, Compliance, & Corporate Development Officer Comp: $363.37kMr. Keith J. Sullivan (Age 66)Director & Advisor to MiraDry Business Comp: $40kMs. Caroline F. Van Hove (Age 43)Executive Chair of Board of Directors Comp: $197.74kDr. Denise DajlesChief Technical OfficerMr. Mark S. Saxton (Age 59)Senior Vice President Sales Ms. Adelle WalkerSenior Vice President of Corporate Strategy & MarketingMr. Matt HostetlerChief People OfficerMore ExecutivesKey CompetitorsINVO BioscienceNASDAQ:INVOCyclacel PharmaceuticalsNASDAQ:CYCCInMed PharmaceuticalsNASDAQ:INMQualigen TherapeuticsNASDAQ:QLGNWindtree TherapeuticsNASDAQ:WINTView All CompetitorsInstitutional OwnershipRTW Investments LPSold 223,020 shares on 2/14/2024Ownership: 0.677%Evoke Wealth LLCBought 26,473 shares on 2/12/2024Ownership: 0.370%View All Institutional Transactions SIEN Stock Analysis - Frequently Asked Questions Should I buy or sell Sientra stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SIEN shares. View SIEN analyst ratings or view top-rated stocks. What is Sientra's stock price target for 2024? 2 analysts have issued 1 year price targets for Sientra's shares. Their SIEN share price targets range from $5.00 to $10.00. On average, they predict the company's share price to reach $7.50 in the next year. This suggests a possible upside of 4,210.3% from the stock's current price. View analysts price targets for SIEN or view top-rated stocks among Wall Street analysts. How have SIEN shares performed in 2024? Sientra's stock was trading at $0.61 on January 1st, 2024. Since then, SIEN shares have decreased by 71.5% and is now trading at $0.1740. View the best growth stocks for 2024 here. When is Sientra's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, April 4th 2024. View our SIEN earnings forecast. How were Sientra's earnings last quarter? Sientra, Inc. (NASDAQ:SIEN) announced its earnings results on Wednesday, November, 10th. The medical instruments supplier reported ($0.80) EPS for the quarter, beating analysts' consensus estimates of ($2.60) by $1.80. The medical instruments supplier had revenue of $19.62 million for the quarter, compared to analysts' expectations of $18.10 million. During the same quarter in the previous year, the company posted ($3.30) earnings per share. When did Sientra's stock split? Sientra's stock reverse split before market open on Monday, January 23rd 2023. The 1-10 reverse split was announced on Monday, January 23rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of Sientra own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sientra investors own include Rigel Pharmaceuticals (RIGL), Matinas BioPharma (MTNB), Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), ADMA Biologics (ADMA), Miragen Therapeutics (MGEN), Corbus Pharmaceuticals (CRBP), Dynavax Technologies (DVAX), Micron Technology (MU) and Novavax (NVAX). Who are Sientra's major shareholders? Sientra's stock is owned by a variety of retail and institutional investors. Top institutional investors include RTW Investments LP (0.68%), Evoke Wealth LLC (0.37%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Andrew C Schmidt, Andrew C Schmidt, Hove Caroline F Van, Oliver Christian Bennett, Ronald Menezes and Valerie J Miller. View institutional ownership trends. How do I buy shares of Sientra? Shares of SIEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SIEN) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceDid you make $29,000 two days with AI options trades?Prosper Trading AcademyThe world’s greatest investmentPorter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sientra, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.